Tolerance, kinetics and depth of response for subcutaneous versus intravenous administration of bortezomib combination in Chinese newly diagnosed multiple myeloma patients

The retrospectively investigation compared the efficacy and safety of Bortezomib (Btz) administration via subcutaneous (SC) and intravenous (IV) in 307 newly-diagnosed multiple myeloma (NDMM) patients from a single Chinese center. SC Btz is associated with better tolerance. However, IV administratio...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Lymphoma Myeloma Leuk
Main Authors: Xu, Yan, Deng, Shuhui, Mao, Xuehan, An, Gang, Li, Zengjun, Wang, Yafei, Fulciniti, Mariateresa, Ho, Matthew, Lin, Jianhong, Sui, Weiwei, Liu, Wei, Zou, Dehui, Yi, Shuhua, Huang, Wenyang, Liu, Hong, Lv, Rui, Li, Jian, Wang, Tingyu, Du, Chenxing, Munshi, Nikhil C, Qiu, Lugui
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5970050/
https://ncbi.nlm.nih.gov/pubmed/29625927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2018.03.006
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares